Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. AbbVie Inc. (NYSE:ABBV) engages in the research and development, manufacture, and sale of medicines and therapies worldwide. It is set to report its Q4 2025 earnings on Jan. 30. Wall Street analysts expect the company to post EPS of $3.36, up from $2.16 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $16.39 billion, up from $15.10 billion a year earlier. Don't Mi ...